Cargando…
Anti-Tumor Effects of a Penetratin Peptide Targeting Transcription of E2F-1, 2 and 3a Is Enhanced When Used in Combination with Pemetrexed or Cisplatin
SIMPLE SUMMARY: The E2F family of transcription factors are essential for cell proliferation, differentiation, and DNA repair. They are commonly overexpressed or dysregulated in cancer as a consequence of inactivation or mutations in the retinoblastoma protein. Therefore, one or more of the activati...
Autores principales: | Rather, Gulam Mohmad, Anyanwu, Michael, Minko, Tamara, Garbuzenko, Olga, Szekely, Zoltan, Bertino, Joseph R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956530/ https://www.ncbi.nlm.nih.gov/pubmed/33652640 http://dx.doi.org/10.3390/cancers13050972 |
Ejemplares similares
-
Modeling and antitumor studies of a modified L–penetratin peptide targeting E2F in lung cancer and prostate cancer
por: Shaik, Tazeem, et al.
Publicado: (2018) -
A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts
por: Xie, Xiaoqi, et al.
Publicado: (2014) -
A Novel Antibody-Toxin Conjugate to Treat Mantle Cell Lymphoma
por: Rather, Gulam M., et al.
Publicado: (2019) -
The Homeodomain Derived Peptide Penetratin Induces Curvature of Fluid Membrane Domains
por: Lamazière, Antonin, et al.
Publicado: (2008) -
Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage
por: Betigeri, Seema, et al.
Publicado: (2010)